Evaluation of immune infiltration in the colonic mucosa of patients with ipilimumab-related colitis

Approximately 30% of patients treated with ipilimumab will develop gastrointestinal toxicity. The immunological drivers that underpin the clinical observations in human tissues are poorly understood. We report here on the immune consequences of ipilimumab treatment in the colorectal mucosa of patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Arriola, Edurne, Wheater, Matthew, Lopez, Maria Antonette, Thomas, Gareth, Ottensmeier, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5048766/
https://www.ncbi.nlm.nih.gov/pubmed/27757302
http://dx.doi.org/10.1080/2162402X.2016.1209615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5048766/
https://www.ncbi.nlm.nih.gov/pubmed/27757302
http://dx.doi.org/10.1080/2162402X.2016.1209615

Ejemplares similares